Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tingli Guo"'
Autor:
Na Liu, Xin Cui, Wenhui Yan, Tingli Guo, Zhuanzhuan Wang, Xiaotong Wei, Yuzhuo Sun, Jieyun Liu, Cheng Xian, Weina Ma, Lina Chen
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 14, Iss 8, Pp 100968- (2024)
There is increasing evidence that the activation of glucagon-like peptide-1 receptor (GLP-1R) can be used as a therapeutic intervention for cognitive disorders. Here, we have screened GLP-1R targeted compounds from Scutellaria baicalensis, which reve
Externí odkaz:
https://doaj.org/article/0b77bb30e444440c879859b2c5637d82
Autor:
Tingli Guo, Wenhui Yan, Xin Cui, Na Liu, Xiaotong Wei, Yuzhuo Sun, KeXin Fan, Jieyun Liu, Yuanyuan Zhu, Zhuanzhuan Wang, Yilei Zhang, Lina Chen
Publikováno v:
Molecular Medicine, Vol 29, Iss 1, Pp 1-17 (2023)
Abstract Background Non-alcoholic fatty liver disease (NAFLD) is one of the most common complications of type 2 diabetes mellitus (T2DM). The pathogenesis of NAFLD involves multiple biological changes, including insulin resistance, oxidative stress,
Externí odkaz:
https://doaj.org/article/2535d181d9854339ac5dfd3b41529ddd
Autor:
Meng Zhang, Wenhui Yan, Ye Yu, Jie Cheng, Xinyao Yi, Tingli Guo, Na Liu, Jia Shang, Zhuanzhuan Wang, Hao Hu, Lina Chen
Publikováno v:
Journal of Pharmacological Sciences, Vol 147, Iss 3, Pp 234-244 (2021)
The incidence of diabetes–associated cognitive dysfunction is increasing. However, few clinical interventions are available to prevent the disorder. Several researches have shown that liraglutide, as a glucagon-like peptide-1 analog, has protective
Externí odkaz:
https://doaj.org/article/5b7d4589da4b4b52a1c39c425ce4decb
Autor:
Xinyao Yi, Wenhui Yan, Tingli Guo, Na Liu, Zhuanzhuan Wang, Jia Shang, Xiaotong Wei, Xin Cui, Yuzhuo Sun, Shuting Ren, Lina Chen
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Diabetic nephropathy (DN), one of the most detrimental microvascular complications of diabetes, is the leading cause of end-stage renal disease. The pathogenesis of DN is complicated, including hemodynamic changes, inflammatory response, oxidative st
Externí odkaz:
https://doaj.org/article/c55b896b23c44d8ba2871ab67c8dc854
Autor:
Tingli Guo, Ye Yu, Wenhui Yan, Meng Zhang, Xinyao Yi, Na Liu, Xin Cui, Xiaotong Wei, Yuzhuo Sun, Zhuanzhuan Wang, Jia Shang, Wei Cui, Lina Chen
Publikováno v:
Experimental Neurology. 365:114414
Autor:
Xinyao Yi, Jia Shang, Lina Chen, Jie Cheng, Ye Yu, Meng Zhang, Tingli Guo, Na Liu, Hao Hu, Zhuanzhuan Wang, Wenhui Yan
Publikováno v:
Journal of Pharmacological Sciences, Vol 147, Iss 3, Pp 234-244 (2021)
The incidence of diabetes–associated cognitive dysfunction is increasing. However, few clinical interventions are available to prevent the disorder. Several researches have shown that liraglutide, as a glucagon-like peptide-1 analog, has protective
Autor:
Lina Chen, Meng Zhang, Tingli Guo, Huangui Xiong, Hao Hu, Mingxia Chen, Qiang Sun, Xinyao Yi, Ye Yu, Wenhui Yan
Publikováno v:
Experimental Neurology. 320:112988
The voltage-gated potassium (Kv) channel blockers tetraethylammonium (TEA) and 4-aminopyridine (4-AP) have shown beneficial effects on some neurological disorders. But their involvements in diabetes-associated cognitive dysfunction are still unknown.
Autor:
Xilan Gou, Miao Pang, Yutong Zhang, Meng Zhang, Ye Yu, Lina Chen, Peiru Si, Xinyao Yi, Tingli Guo, Wenhui Yan, Alina Zhawatibai
Publikováno v:
Life Sciences. 231:116566
Aims Diabetes mellitus can cause cognitive impairments, a state between normal aging and dementia. Effective clinical interventions are urgently needed to prevent or treat this complication. Liraglutide as a glucagon–like peptide 1 analog has been